Tozinamerán

Records for this ingredient, by country (identity only).

ATC J07BN01 · 4 markets · 23 records

Tozinamerán 4 markets · 23 records Forms
Filters
MarketSG 5
Kind

SG 5 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

  • 15 mcg/dose per mL / per unit basis not statedinjection CombinationFamtozinameran 15 mcg/dose + Tozinamerán 15 mcg/doseCOMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 15/15 MICROGRAMS/DOSE (MULTI-DOSE VIAL)COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 15/15 MICROGRAMS/DOSE (SINGLE-DOSE VIAL)
  • 5 mcg/dose per mL / per unit basis not statedinjection CombinationFamtozinameran 5 mcg/dose + Tozinamerán 5 mcg/doseCOMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 5/5 MICROGRAMS/DOSE (MDV)COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 5/5 MICROGRAMS/DOSE (SINGLE-DOSE VIAL)
  • 1.5 mcg/dose per mL / per unit basis not statedinjection CombinationFamtozinameran 1.5 mcg/dose + Tozinamerán 1.5 mcg/doseCOMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.